2024年体外诊断试剂业务展望（更新6次）

In Vitro Diagnostics Business Outlook, 2024 (6 Updates)

出版日期: 2024年01月01日 | 出版商:

Kalorama Information | 英文 | 商品交期: 最快1-2个工作天内

价格

简介目录

体外诊断业务展望每双月出版一次，每年六次。

样本

该报告探讨了体外诊断业务的前景，并提供了独特的资讯和数据，包括：

市场数据和预测（成长率、市场规模、市场占有率）以确定成长机会
全面瞭解 IVD 市场，涵盖测试类别和公司概况
併购活动、精心挑选的合作伙伴关係和合作、合作协议等。
对策略规划有用的产业和区域趋势
分析新闻和事件，报导难以找到的新闻

简介目录

Product Code: 24-014

"In Vitro Diagnostics Business Outlook" is a bimonthly publication with six issues annually.

SAMPLE VIEW

"In Vitro Diagnostics Business Outlook" offers information and data that you cannot get anywhere else, including:

Market data and forecasts (growth rates, market size, market share, etc.) to identify growth opportunities
A comprehensive view of the IVD market with test categories covered and company briefs
M&A activities, selected partnerships & collaborations, partnership deals, and more
Industry & region watch to help tailor strategies
Analysis of news and events and reporting on news not easily available

Volume 3, Issue 1 – Focus on Molecular HLA Testing

Market Analysis: Molecular HLA/Transplant Testing

Overview of Molecular HLA/Transplant Testing
Market Outlook
Regional Market
Top Company Briefs
- Immucor
- Luminex/DiaSorin
- CareDx
- Thermo Fisher Scientific
Executive News Briefing
- DEKFI Diagnostics Appoint New CEO
- Onera Raises $32 Million in Funding
- Cleveland Diagnostics Completes $75 Million in Funding
Financial Highlights: Agilent and Hologic
Agilent Full Year Fiscal 2023 Sales up 1.5% in Core Business YOY
- Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2022 and FY 2023
- Figure: Agilent Sales, by Business (Agilent CrossLab Group, Diagnostics and Genomics Group, Life Sciences and Applied Markets Group), FY 2023 Quarterly Performance
- Table: Agilent Revenue Mix, by Type (Consumables/Services/Informatics and Instruments), FY 2023 (%)
- Figure: Agilent FY 2023 Regional Sales Breakdown Distribution, by Region (Americas, Asia Pacific, Europe) (%)
Hologic Supports Strong Financial Performance in Full-Year Fiscal Year Guidance
- Table: Hologic Diagnostic Sales Performance, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2023 ($ millions)
- Figure: Hologic Revenue, by Product Group (Blood Screening, Cytology & Perinatal, Molecular Diagnostics), FY 2022 and FY 2023 ($ millions)
- Figure: Hologic Geographic Revenue Distribution, by Region (Asia Pacific, Europe, United States, All Others), FY 2023 (%)
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals Partnerships and Collaborations
Industry Watch
COVID-19 Update
Region Watch
- India
  - Figure: India Real GDP Growth, Inflation Rate (consumer prices), 2017-2024
  - Figure: India IVD Market Distribution of Sales, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023 (%)
- Saudi Arabia
  - Figure: Saudi Arabia Population Pyramid, 2023 and 2053
  - Figure: Saudi Arabia Total Annual Liquid Fuels Production and Consumption, 2013-2022 (millions of barrels)
  - Figure: Saudi Arabia IVD Market Share, by Broad IVD Segment (Chemistry/Hematology/Coagulation, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care Glucose, Other Segments), 2023
- Broad-based Company Announcements
- QuidelOrtho Obtains FDA Nod
- Illumina Plans to Divest Grail
- Roche to Acquire LumiraDx
- QIAGEN Expands Footprint with New Regional Headquarters in Middle East

Volume 3, Issue 2 – Focus on Immunoassay Overview

Market Analysis
Overview of IVD Immunoassay
Market Outlook
- Table: Global Lab-Based Immunoassay Market by Segment, 2023-2028 ($ millions)
- Figure: Global Lab-Based Immunoassay Market, by Segment, 2023-2028 ($ millions)
Regional Market
- Table: Global Immunoassay Market (Lab-Based) Sales Distribution, by Region, 2023 (%) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
- Figure: Global Immunoassay Market Sales Distribution, Top 10 Country Markets, 2023 (%)
Top Company Briefs
- Roche
- Abbott Diagnostics
- Siemens Healthineers
- Other Selected Immunoassay News
Executive News Briefing
- NOWDiagnostics Selects New Science Officer
- Freenome Raises $254 Million in New Funding
- QuidelOrtho Axes CEO
- Agilent CEO to Retire
Financial Highlights: Bio-Rad Laboratories and Veracyte
Bio-Rad Laboratories Reports Full-Year 2023 Clinical Diagnostics Revenues up 3.2% over previous year
- Table: Bio-Rad Laboratories Net Sales, 2021-2023 ($M)
- Figure: Bio-Rad Laboratories Sales by Business, 2022 vs. 2023, $M
- Figure: Bio-Rad Laboratories Quarterly Performance by Business, 2022 vs. 2023 ($M)
- Figure: Bio-Rad Laboratories 2022 and 2023 Regional Sales Breakdown Distribution
Veracyte Reported Strong Performance in 2023
- Figure: Veracyte 12-Month (FY22 and FY23) Sales by Division (Testing, Product, Biopharmaceutical and Other), Thousands USD
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
Virus Testing Update
Region Watch
- Peru
  - Figure: Peru Population Distribution by Broad Age Group, 2023 and 2040 Estimates
  - Figure: Peru GDP Value and Growth by Year, 2010-2022
  - Figure: Peru COVID-19 Lab Samples Tested and Positivity by Region, Cumulative 2020-2023
- South Africa
  - Figure: South Africa Population Pyramid, 2023 and 2033 Estimates
  - Figure: South Africa GDP, Composition by Sector (Agriculture, Industry, Services)
- Broad-based Company Announcements
- Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome
- DiaSorin Nabs FDA Clearance for New LIAISON PLEX System
- T2 Biosystems Offers Expanded Panel
- Cepheid Received FDA Clearance for Xpert Xpress GBS
- DiaCarta Collaboration to Launch Prostate Cancer LDT

Volume 3, Issue 3 – Clinical Chemistry

Market Analysis: Clinical Chemistry
Overview of Clinical Chemistry Market
Market Outlook
- Table: Clinical Chemistry Diagnostic Sales, by Broad Test Category, 2023 ($ millions)
- Figure: Clinical Chemistry Diagnostic Market Distribution, by Broad Test Category, 2023 (%)
Major Product Activity
- Lab-based Clinical Chemistry
- Table: Market Summary: Lab-based Clinical Chemistry Market, by Segment, 2023 and 2028 ($ millions)
- Point-of-Care Clinical Chemistry
- Table: Market Summary: POC-based Clinical Chemistry Market, 2023 and 2028 ($ millions)
Regional Market
- Figure: Global Clinical Chemistry Sales Estimates and Projection, by Region, 2023 and 2028 ($ millions)
- Table: Global Clinical Chemistry Sales Distribution, by Region, 2023 (%)
Top Company Briefs
- Roche
- Abbott
- Danaher
Executive News Briefing
- Cue Health Calls It Quits
- Allenz Health Secures $60 Million in Funding
- Next Gen Diagnostics Welcomes New Scientific Advisory Board Member
- Next Gen Diagnostics Opens First U.S. Laboratory
Financial Highlights: bioMérieux & Sekisui Diagnostics
- Figure: bioMérieux Sales Distribution, by Business Segment, 2023 (%)
- Table: bioMérieux Financial Review, by Business Segment, FY 2022 – FY 2-23 (€M)
- Figure: bioMérieux FY 2022 vs FY 2023 Regional Sales Breakdown (€M)
- Table: Sekisui Chemical Financial Results, FY 2022 and FY 2023 (Billions of Yen)
- Table: Sekisui Chemical Annual Overview and Focus, FY 2023 and FY 2024 (Billions of Yen)
- Table: Sekisui Chemical Net Sales, by Segment, FY22 and FY23 (Billions of Yen)
- Figure: Sekisui Chemical Medical Division, Revenue Mix, by Type, by Quarter, Q1 FY22 – Q4FY23 (Millions of Yen)
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
Partnerships and Collaborations
Industry Watch
COVID-19/Flu Update
Region Watch
- Japan
  - Figure: Japan National Health Expenditures, Year-on-Year Growth Rate, 1985-2019 (Yen trillion, %)
  - Figure: Japan: Changes in Number of Hospitals, by Hospital Type, 2015-2019
  - Figure: Japan: Changes in Number of Beds, by Bed Type and Number of Beds per Hospital, 2015-2019
  - Figure: Japan: Changes in Average Length of Stay, by Bed Type, 2015-2019
  - Figure: Japan IVD Market, by Segment, 2023 (%)
Broad-based Company Announcements
Announcements
QIAGEN Launches Gastrointestinal Molecular Panel in the United States
Illumina Spins Off Grail
QIAGEN Discontinues NeuMoDx System
DiaSorin Nabs Clearance for LIAISON PLEX Blood Culture Yeast Assay
Genetic Signatures Granted FDA Clearance for GI Kit

Volume 3, Issue 4 – Blood Screening

OVERVIEW OF BLOOD SCREENING
MARKET OUTLOOK
- Figure: Blood Screening Market, 2019-2029 ($ billion)
- Figure: Blood Screening Sales, by Test Method, 2024 and 2029 ($ billion) (Immunoassay Screen, NAT Screens)
- Figure: Blood Donation Screening Market Distribution, by Analyte, 2024 (%) (Hepatitis, HIV, Other)
REGIONAL MARKET
- Table: Estimated Blood Donations, by WHO Region, 2018
- Figure: Whole Blood Donations per 1000 Population, 2018
- Table: Blood Screening Market Distribution, by Global Region, 2024 (%) (Asia Pacific, Europe, North America, RoW)
- Figure: Blood Screening Market Distribution of Sales, by Global Region (%) (Asia Pacific, Europe, North America, RoW)
Segment Activity by Region
- Immunoassays
- Figure: Market Summary: Immunoassay Blood Screening Market, Distribution of Sales, by Region, 2024 (%) (Asia Pacific, Europe, North America, RoW)
- Molecular
- Figure: Market Summary: NAT Blood Screening Market, Distribution of Sales by Region (North America, Europe, Asia Pacific, RoW), 2024
TOP COMPANY BRIEFS
Roche
Grifols
Abbott
EXECUTIVE NEWS BRIEFING
BRIEFS
Trinity Biotech Engages New CCO
BillionToOne Closes Financing Deal
OraSure Technologies Elects New Board Member
Viome Life Sciences Secures $25 Million in Financing
Syantra Raises $3.6 Million in A-1 Round Financing
FINANCIAL HIGHLIGHTS: DEXCOM AND EXACT SCIENCES
Dexcom Revenues Increase 15% (+$133 million) in Q2 2024
- Figure: Dexcom Revenue Mix, by Product Segment, Q2 2023 and Q2 2024
- Figure: Dexcom Revenue Mix by Product Segment, By Quarter 2022 – Q2 2024
- Table: Dexcom Geographic Revenues, by Region, Q2 2023 and Q2 2024 ($ million)
Exact Sciences Reports it : Tested a Record Number of Cancer Patients with Oncotype DX
- Figure: Exact Sciences Revenue Mix, by Product Segment, Q2 2023 vs Q2 2024 ($ million)
- Figure: Exact Sciences Revenue Mix, by Product Segment, by Quarter 2022-Q2 2024 ($ million)
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS
PARTNERSHIPS AND COLLABORATIONS
MERGERS AND ACQUISITIONS
- Table: Selected Diagnostic Market Mergers and Acquisitions Deals
REGION WATCH
- Figure: South Korea GDP, GDP (PPP), and Health Spending, CAGR 2005-2010, 2010-2015, 2015-2020 and 2020-2023 (%)
- Figure: South Korea Medical Tourism Visits Reported, 2009-2023 (# of patients)
- Figure: South Korea Old-Age Dependency Ratio and Aging Index, 1980-2065
BROAD-BASED COMPANY ANNOUNCEMENTS
ANNOUNCEMENTS
Foundation Medicine Gets the Nod for Its Companion Diagnostics
QuidelOrtho Proud to Announce Clearance for VITROS Syphilis Assay
AliveDx Receives IVDR-CE Mark for Multiplexed Assay
T2 Biosystems Scores FDA Pediatric Clearance
ID-FISH Technology Announces FDA Nod for its Lyme ImmunoBlot

Volume 3, Issue 5 – Point-of-Care (POC)

Market Analysis: IVD POC Testing
Overview of IVD POC Testing
Market Outlook
- Table: Global POC Diagnostic Market, by Broad Segment, 2024 and 2029 ($ million) (professional testing, self-testing)
- Figure: Point-of-Care Diagnostics (COVID-19 vs. non-COVID testing), 2020-2024 ($ million)
- Figure: Global POC Diagnostic Market Distribution, by Segment, 2024 (%) (Cardiac Care; Coagulation; Critical Care; Drug of Abuse; Fecal Occult Blood; Glucose; Hematology; Infectious Disease Lipid [Cholesterol]; Pregnancy/Fertility; Urinalysis; Others)
Selected Product Activity
Regional Market
- Figure: POC Diagnostics Market Value, by Global Region, 2024 ($ million) (North America, Europe, Asia Pacific, Latin America, Middle East, Africa)
Company Briefs
Abbott Diagnostics
Dexcom
Roche
Executive News Briefing
Briefs
Quanterix Appoints New Member to Board of Directors
Beckman Coulter Appoints New President
MARAbio Raises $19 Million in Series A Funding
Amprion Makes Advances in Series B Financing
Sunbird Bio Closes $14 Million Financing Round
Bruker Reported 17% Growth in Second Quarter 2024 and 11% Growth for the First Six Months
- Figure: Bruker Corporation Sales, by Business, H1 2023 Compared to H1 2024 (Bruker BioSpin, Bruker CALID, Bruker Nano, BEST, Eliminations)
- Figure: Bruker CALID Quarterly Performance, Sales by Quarter, Q1 2022 – Q2 2024
- Figure: Bruker Corporation H1 2023 and H1 2024 Regional Sales Breakdown Distribution (Asia Pacific, Japan; Europe; United States; Other)
Myriad Genetics Reports 13% Revenue Growth in First Half 2024
- Table: Myriad Genetics Revenue Mix, by Product, H1 2023 vs H1 2024 ($ million) (Hereditary Cancer; Pharmacogenomics; Prenatal; Tumor Profiling)
- Figure: Myriad Genetics Revenue Mix, by Business Unit, Quarterly Performance Q1 2023 through Q2 2024 ($ million) (Mental Health, Oncology, Womens Health)
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Partnerships and Collaborations
Mergers and Acquisitions
- Table: Recent Diagnostic Market Mergers, Acquisitions and Partnership Deals
Industry Watch
Industry Watch COVID-19/Flu Update
Region Watch
Finland
- Figure: Finland GDP Value and Growth, by Year, 2013-2023 ($ billion)
- Figure: Finland Social Protection Expenditure by Function, 1995-2022 in 2022 Prices (€ billion)
- Figure: Finland IVD Market, 2019-2024 ($ million)
Broad-based Company Announcements
Announcements
Roche Launches TAGS Technology Test
Exact Sciences Welcomes New Cologuard Plus Test
PreAnalytiX Launches PAXgene Urine Liquid Biopsy Set
Abionic Launches Early Sepsis Test
QIAGEN Expands Liquid Biopsy Portfolio
FoundationOne Gains Liquid CDx Approval
Revvitys Euroimmun Announces Groundbreaking Launch in the EU

Volume 3, Issue 6 – Glucose Testing

MARKET ANALYSIS: IVD GLUCOSE TESTING

OVERVIEW OF IVD GLUCOSE TESTING

MARKET OUTLOOK
- Table: Global Diabetes Sales, by Test Category, 2024-2029 ($ million) (Glucose OTC; Glucose Professional; Glucose, Continuous; HbA1c POC; HbA1c Lab)
- Figure: Global Diabetes Testing Market, by Segment with CAGR 2024-2029 ($ million) (Glucose OTC; Glucose Professional; Glucose, Continuous; HbA1c POC; HbA1c Lab)
REGIONAL MARKET
- Figure: Global Diabetes Prevalence, 20-79y, 2021 Estimates (per 1,000s)
- Figure: Global Distribution, Diabetes Test Market, 2024 (%) (Glucose, HbA1c)
COMPANY BRIEFS
Abbott Diagnostics
Dexcom
Roche

EXECUTIVE NEWS BRIEFING

BRIEFS
Agilent Reorganizes Business Units
Natera Co-Founder Named R&D Leader of the Year
QIAGEN Moves QIAstat-Dx to Drive Growth
OraSure Receives Funding
AmplifiDx Captures Additional Funding
52North Closes $6 Million in Funding

FINANCIAL HIGHLIGHTS: ABBOTT LABORATORIES, QIAGEN

ABBOTT CONTINUES STEADY PERFORMANCE IN 2024; 9M SALES INCREASE 3.7%
- Figure: Abbott Sales by Business, 9M 2023 and 9M 2024 ($ million)
- Table: Diagnostic Sales, Abbott Laboratories, 9M 2023 and 2024 ($ million)
- Figure: Diagnostic Sales, Abbott Laboratories, 9M 2023 and 2024 ($ million)
- Table: COVID-19 Test Sales, Abbott Laboratories, 9M 2023 and 2024 ($ million)
- Figure: Diabetes Care, Abbott Laboratories, 9M 2023 and 9M 2024 ($ million)
QIAGEN REPORTS STRONG PERFORMANCE IN Q3 2024; RAISES GUIDANCE
- Figure: QIAGEN Revenue Mix by Business Segment, 9M 2024 ($ million) (Molecular Diagnostics, Life Sciences)
- Figure: QIAGEN Sales by Product Group, 9M 2024 ($ million) (Sample Technologies, Diagnostic Solutions, PCR/Nucleic Acid Amplification, Genomics/NGS, Other)
- Table: QIAGEN Sales, by Product Type, 9M 2023 and 9M 2024 ($ million) (CAGR %) (Consumables and Related Revenues, Instruments)
- Figure: QIAGEN Diagnostic Solutions Sales, by Segment, 9M 2023 and 9M 2024 ($ million) (QuantiFERON, QIAstat-Dx, NeuMoDx, Other)
- Figure: QIAGEN Sales, by Geographic Region, 9M 2023 and 9M 2024 ($ million) (Americas, EMEA, Asia Pacific/Japan)

DIAGNOSTIC MARKET MERGERS, ACQUISITIONS AND PARTNERSHIP DEALS

PARTNERSHIPS AND COLLABORATIONS
MERGERS AND ACQUISITIONS
- Table: Recent Diagnostic Market Mergers, Acquisitions and Partnership Deals, Dec. 2023-Nov. 2024

INDUSTRY WATCH

INDUSTRY WATCH COVID-19/FLU UPDATE

REGION WATCH

VIETNAM
- Figure: Vietnam GDP, Composition by Sector, 2023 (%) (Agriculture, Forestry, Fishery; Industry, Construction; Services)
- Figure: Vietnam GDP Value and Growth by Year, 2015-2023 ($ billion)